A Phase 2 study of S-237648 in Japanese obese patients with impaired glucose tolerance/type 2 diabetes mellitus and hyperlipidemia
Phase 2
- Conditions
- Obesity
- Registration Number
- JPRN-jRCT2080222949
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
[Main inclusion criteria]
1.With BMI >=25.0
2.With visceral fat area >=100 cm2
3.Patients who meets following criteria
A)Previously diagnosed with glucose intolerance or type 2 diabetes [HbA1c >=6.5% to <9.0% (NGSP)]
B)Previously diagnosed as hyperlipidemia with TG >=150 mg/dL and/or HDL-C <40 mg/dL and/or LDL-C >=140 mg/d
Exclusion Criteria
[Main exclusion criteria]
1.Patients with symptomatic obesity
2.Patients with serious hepatic, renal, cardiovascular, respiratory, or hematological disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method